Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02945436 · ClinicalTrials.gov registry record · NA
Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
NCT02945436: Completed NA study, sponsored by University of Michigan.
NCT02945436 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 258 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02945436, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
Study Summary
A sample of 300 young (15-29) men who have sex with men (MSM) and transgender persons living in South-East Michigan's Detroit Metro Area (DMA) will be recruited through venue-based sampling and online ads to examine the efficacy of adding a substance use brief intervention (SUBI) to standard HIV prevention and care (SOC) for achieving gains in successful engagement in HIV care. The investigators will partner with Detroit-area AIDS Service Organizations (ASOs) to deliver the intervention.
Primary Outcome
Increases in repeat HIV testing as measured by the "HIV Testing Questions" section of the questionnaires
Interventions
- BEHAVIORAL Standard of Care (SOC)
- BEHAVIORAL Substance Use Brief Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2017-04-07 |
| Est. Completion | 2021-06-01 |
| Phase | NA |
What the finished NCT02945436 record still lists
NCT02945436 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care (SOC) is the first listed.
NCT02945436 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02945436 about?
NCT02945436 is a clinical study titled "Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention". A sample of 300 young (15-29) men who have sex with men (MSM) and transgender persons living in South-East Michigan's Detroit Metro Area (DMA) will be recruited through venue-based sampling and online ads to examine the efficacy of adding a substance use brief intervention (SUBI) to standard HIV pre...
What is the current status of trial NCT02945436?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2017-04-07. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT02945436?
The interventions under investigation include: Standard of Care (SOC) (BEHAVIORAL), Substance Use Brief Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02945436?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02945436's enrollment target sits among peer trials
258 402nd of 2000 higher than 1,598 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI